2012

2/9/2012
Researchers Study Mitochondrial Function, Potential New Therapeutic Target for Alzheimer's Disease

1/31/2012
Metabolic Solutions Development Company previews latest findings on newly identified potential mechanism of action for insulin sensitization at Keystone Symposium on Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms 

2011

12/01/2011
Metabolic Solutions Development Company, LLC to present at Windhover’s 6th annual Therapeutic Area Partnerships meeting

11/17/2011
Metabolic Solutions Jandernoa Receives Spirit of Michigan Award

10/6/11
Metabolic Solutions Development Company Receives $1.1 Million NIH Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease

9/8/11
Metabolic Solutions Development Company presents new brown fat research at the European Association for the Study of Diabetes

9/8/11
Metabolic Solutions Development Company Reports Positive Top-Line Results From 2a Trial of its Second Compound to Treat Type 2 Diabetes

7/6/11
Metabolic Solutions Development Company Receives $773,000 From Alzheimers Drug Discovery Foundation To Fund Phase 2a Trial

6/21/11
MSDC to Present Recent Findings at American Diabetes Association Conference

3/29/2011
Metabolic Solutions Development Company Launches Phase 2a Trial of its Second Compound to Treat Type 2 Diabetes

3/7/2011
Metabolic Solutions Development Company President and Co-Founder to Speak at Diabetes Summit

2010

10/21/2010
Metabolic Solutions Development Company Raises Approximately $23.5 Million; Plans to Launch Phase 2b Trial

9/16/2010
Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes

6/15/2010
Metabolic Solutions Development Company to Present Research Findings at Annual American Diabetes Association Conference

4/8/2010
Metabolic Solutions Development Company Named One of 50 Michigan Companies to Watch

2009

10/12/2009
Metabolic Solutions Development Company To Test Potential Treatment For Alzheimer's.

5/14/09
Metabolic Solutions Development Company announces preliminary results from Phase IIa clinical trial.

4/29/09
Metabolic Solutions Development Company secures more than $10 Million for further development of its diabetes drug portfolio.

2008

09/30/08
West Michigan drug research company set to begin major clinical trial of diabetes drug

05/28/08
Dr. John Landis joins Board of Directors of Metabolic Solutions Development Co.